Table 8 Logistic regression analysis of related risk factors for triple-vessel of CAD.
From: Implications of C1q/TNF-related protein superfamily in patients with coronary artery disease
Variable | Univariate Analysis | ||
|---|---|---|---|
OR | ORCI95% | P | |
Sex(M/F) | 1.588 | 0.670–3.763 | 0.293 |
Age(year) | 1.019 | 0.978–1.061 | 0.363 |
Occlusion(N/Y) | 3.000* | 1.079–8.341 | 0.035 |
Hypertension(N/Y) | 1.747 | 0.812–3.760 | 0.154 |
Diabetes(N/Y) | 1.588 | 0.670–3.763 | 0.293 |
Smoker(N/Y) | 3.69* | 1.04–13.07 | 0.043 |
TC(mmol/L) | 1.162 | 0.837–1.613 | 0.370 |
TG(mmol/L) | 1.278 | 0.945–1.727 | 0.112 |
HDL-C(mmol/L) | 2.170 | 0.768–6.131 | 0.144 |
LDL-C(mmol/L) | 1.346 | 0.974–1.859 | 0.071 |
ALT(U/L) | 1.005 | 0.996–1.014 | 0.391 |
AST(U/L) | 1.007 | 0.995–1.018 | 0.263 |
EF(%) | 0.986 | 0.92–1.02 | 0.531 |
CTRP1(ng/ml) | 1.052* | 1.006–1.099 | 0.025 |
CTRP5(ng/ml) | 0.971 | 0.925–1.020 | 0.243 |
CTRP7(ng/ml) | 1.002 | 0.996–1.007 | 0.621 |
CTRP15(ng/ml) | 0.994 | 0.982–1.006 | 0.334 |
